10
line antiretroviral Efavirenz is used AZT +3 TC + EFV. Whereas if the HIVAIDS patients with TB opportunistic infections does not use Rifampicin, it can still be given a combination
of AZT +3 TC + NVP Depkes RI, 2007a. Selection of antiretroviral combination for patients with TB opportunistic infections
are also based on the specific circumstances of each patient such as anemia and allergic reactions. A total of 7 patients who are allergic to rifampin, they can be replaced with other
OAT namely streptomycin, so that nevirapine can be administered to the patient without interaction. And if the patients hemoglobin level examination is known to have anemia
N.K.N.S, then the provision of Zidovudine AZT is replaced with Stavudine d4T, because AZT has side effects such as anemia. So the appropriate combination given to the
patient is d4T +3TC + EFV. Overview types of TB and ARV combinations used can be seen in the figure below.
Figure 2. ARV Combination used for patients with opportunistic pulmonary infections tuberculosis and KP duplex
In this study, as shown in Figure 2, there are 2 patients who suffer from KP Duplex given the combination of AZT +3TC + EFV. For total of 12 patients with pulmonary
tuberculosis use combination of AZT +3TC + EFV, 7 patients with pulmonary tuberculosis using a combination AZT +3TC + NVP, and 1 pulmonary TB patient using the combination
of d4T +3 TC + EFV. Patient N.K.N.S get therapy combination d4T +3 TC + EFV as having a low hemoglobin level, namely 10 g dl, whereas normal Hb levels in adult women is 12-16
g dl Depkes, 2007a.
5. The increase of CD4
+
toward ARV Combination of HIVAIDS-TB Patient
From changing of total CD4
+
for 1 year of using ARV, it can be monitored an increase or decrease in CD4
+
patients. The increase and decrease of CD4
+
according to CD4
+
can be seen in the table below.
10 12
Am ou
nt o
f Pa
tie nt
10
line antiretroviral Efavirenz is used AZT +3 TC + EFV. Whereas if the HIVAIDS patients with TB opportunistic infections does not use Rifampicin, it can still be given a combination
of AZT +3 TC + NVP Depkes RI, 2007a. Selection of antiretroviral combination for patients with TB opportunistic infections
are also based on the specific circumstances of each patient such as anemia and allergic reactions. A total of 7 patients who are allergic to rifampin, they can be replaced with other
OAT namely streptomycin, so that nevirapine can be administered to the patient without interaction. And if the patients hemoglobin level examination is known to have anemia
N.K.N.S, then the provision of Zidovudine AZT is replaced with Stavudine d4T, because AZT has side effects such as anemia. So the appropriate combination given to the
patient is d4T +3TC + EFV. Overview types of TB and ARV combinations used can be seen in the figure below.
Figure 2. ARV Combination used for patients with opportunistic pulmonary infections tuberculosis and KP duplex
In this study, as shown in Figure 2, there are 2 patients who suffer from KP Duplex given the combination of AZT +3TC + EFV. For total of 12 patients with pulmonary
tuberculosis use combination of AZT +3TC + EFV, 7 patients with pulmonary tuberculosis using a combination AZT +3TC + NVP, and 1 pulmonary TB patient using the combination
of d4T +3 TC + EFV. Patient N.K.N.S get therapy combination d4T +3 TC + EFV as having a low hemoglobin level, namely 10 g dl, whereas normal Hb levels in adult women is 12-16
g dl Depkes, 2007a.
5. The increase of CD4
+
toward ARV Combination of HIVAIDS-TB Patient
From changing of total CD4
+
for 1 year of using ARV, it can be monitored an increase or decrease in CD4
+
patients. The increase and decrease of CD4
+
according to CD4
+
can be seen in the table below.
2 4
6 8
10 12
12 7
1 2
Am ou
nt o
f Pa
tie nt
ARV Combination
TB Pulmonary KP Duplex
10
line antiretroviral Efavirenz is used AZT +3 TC + EFV. Whereas if the HIVAIDS patients with TB opportunistic infections does not use Rifampicin, it can still be given a combination
of AZT +3 TC + NVP Depkes RI, 2007a. Selection of antiretroviral combination for patients with TB opportunistic infections
are also based on the specific circumstances of each patient such as anemia and allergic reactions. A total of 7 patients who are allergic to rifampin, they can be replaced with other
OAT namely streptomycin, so that nevirapine can be administered to the patient without interaction. And if the patients hemoglobin level examination is known to have anemia
N.K.N.S, then the provision of Zidovudine AZT is replaced with Stavudine d4T, because AZT has side effects such as anemia. So the appropriate combination given to the
patient is d4T +3TC + EFV. Overview types of TB and ARV combinations used can be seen in the figure below.
Figure 2. ARV Combination used for patients with opportunistic pulmonary infections tuberculosis and KP duplex
In this study, as shown in Figure 2, there are 2 patients who suffer from KP Duplex given the combination of AZT +3TC + EFV. For total of 12 patients with pulmonary
tuberculosis use combination of AZT +3TC + EFV, 7 patients with pulmonary tuberculosis using a combination AZT +3TC + NVP, and 1 pulmonary TB patient using the combination
of d4T +3 TC + EFV. Patient N.K.N.S get therapy combination d4T +3 TC + EFV as having a low hemoglobin level, namely 10 g dl, whereas normal Hb levels in adult women is 12-16
g dl Depkes, 2007a.
5. The increase of CD4
+
toward ARV Combination of HIVAIDS-TB Patient
From changing of total CD4
+
for 1 year of using ARV, it can be monitored an increase or decrease in CD4
+
patients. The increase and decrease of CD4
+
according to CD4
+
can be seen in the table below.
11
Figure 3. Increase and decrease of CD4 + HIVAIDS-TB in VCT clinic Sanglah Hospital during January-December 2009 based on CD4
+
From the results obtained, the combination of AZT +3 TC + EFV was given to 14 patients whom 12 patients having increased value CD4
+
and 2 patients with a decline value of CD4
+
after the usage of 12 months, whilst the combination of d4T +3TC + NVP given to 7 patients with 6 patients had a increased value of CD4
+
and 1 patient with CD4
+
values decreased after 12 months of use, while d4T +3 TC + EFV combination given to 1 new patient showed
improvement.
6. The increased of CD4
